Zhongyan polymer: plans to increase the capital of its wholly-owned subsidiary Houhe Medical by 45 million yuan.

China Research Institute of High Polymer announced that the company has decided to increase the capital of its wholly-owned subsidiary Houhe Medical by 45 million yuan, bringing its registered capital to 50 million yuan, with the purpose of supporting the subsidiary's business development. Houhe Medical had a net profit of -210,900 yuan in 2024 and -131,900 yuan in the first half of 2025. This capital increase was approved at the fourth interim meeting of the fourth board of directors of the company and does not constitute a related party transaction or major asset restructuring, and still needs to go through industrial and commercial registration changes. In the future, the subsidiary may face various risks, and the company will closely monitor and actively respond to them.